AC
SGMO

Amici Capital’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Amici Capital’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-40,000
Closed -$226K – 127
2015
Q3 		$226K Hold
40,000
– – 0.01% 134
2015
Q2 		$444K Buy
+40,000
New +$516K 0.02% 123
2014
Q4 		– Sell
-25,560
Closed -$276K – 132
2014
Q3 		$276K Hold
25,560
– – 0.01% 140
2014
Q2 		$390K Buy
+25,560
New +$368K 0.01% 131

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Amici Capital's SGMO Position: Q4 2015 in Review

Amici Capital sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2015, closing a stake of 40,000 shares — an estimated $226K sold.

Amici Capital first reported a position in SGMO in Q2 2014 and held it in 4 quarters. The position peaked at $444K in Q2 2015. 141 funds tracked by Wall St. Rank hold SGMO as of Q4 2015.

  • Amici Capital reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2015 after selling out during the quarter.
  • Amici Capital sold 40,000 SANGAMO THERAPEUTICS INC shares in Q4 2015, an estimated $226K.
  • Amici Capital first reported a position in SANGAMO THERAPEUTICS INC in Q2 2014 and held it in 4 quarters.
  • Amici Capital's SANGAMO THERAPEUTICS INC position peaked at $444K in Q2 2015.
  • 141 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2015.

Based on Amici Capital's 13F filing for Q4 2015, filed 16 Feb 2016.